# CF Bronchodilation

> **NCT03522831** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of British Columbia** · enrollment: 20 (estimated)

## Conditions studied

- Lung Diseases
- Cystic Fibrosis

## Interventions

- **DRUG:** Salbutamol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03522831
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03522831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03522831, "CF Bronchodilation". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03522831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*